19 U.S. lawmakers have disclosed 70 Celgene Corporation trades under the STOCK Act — 39 buys and 31 sells between 2012 and 2019. Congress has been net buyers of CELG.
*Notional-weighted price return on lawmakers' disclosed buys of CELG, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2019-10-01 | Pat Roberts | SELL | $1K–$15K | — | — | — exit |
| 2019-07-05 | Mike Kelly | SELL | $1K–$15K | — | — | — exit |
| 2019-06-12 | Mike Kelly | SELL | $1K–$15K | — | — | — exit |
| 2019-02-28 | John F Reed | SELL | $1K–$15K | — | — | — exit |
| 2019-01-02 | Rohit Khanna | BUY | $1K–$15K | — | — | — |
| 2018-12-31 | James M Inhofe | SELL | $15K–$50K | — | — | — exit |
| 2018-12-03 | Rohit Khanna | BUY | $1K–$15K | — | — | — |
| 2018-11-16 | James M Inhofe | SELL | $15K–$50K | — | — | — exit |
| 2018-11-16 | James M Inhofe | SELL | $15K–$50K | — | — | — exit |
| 2018-11-14 | John A. Yarmuth | SELL | $1K–$15K | — | — | — exit |
| 2018-11-09 | Rohit Khanna | BUY | $1K–$15K | — | — | — |
| 2018-10-05 | Gary Palmer | SELL | $1K–$15K | — | — | — exit |
| 2018-08-30 | Zoe Lofgren | SELL | $1K–$15K | — | — | — exit |
| 2018-07-12 | James M Inhofe | BUY | $15K–$50K | — | — | — |
| 2018-05-02 | Kurt Schrader | BUY | $1K–$15K | — | — | — |
| 2018-05-01 | JOHN BOOZMAN | BUY | $1K–$15K | — | — | — |
| 2018-02-22 | James M Inhofe | BUY | $50K–$100K | — | — | — |
| 2018-01-17 | Pat Roberts | BUY | $1K–$15K | — | — | — |
| 2018-01-17 | Pat Roberts | BUY | $1K–$15K | — | — | — |
| 2018-01-11 | John F Reed | SELL | $1K–$15K | — | — | — exit |
| 2018-01-08 | Alan S. Lowenthal | SELL | $838.78–$838.78 | — | — | — exit |
| 2017-11-02 | Alan S. Lowenthal | SELL | $1K–$15K | — | — | — exit |
| 2017-10-23 | Bradley S. Schneider | SELL | $100K–$250K | — | — | — exit |
| 2017-09-07 | Pat Roberts | SELL | $1K–$15K | — | — | — exit |
| 2017-09-07 | Pat Roberts | SELL | $1K–$15K | — | — | — exit |
| 2017-09-07 | Pat Roberts | SELL | $15K–$50K | — | — | — exit |
| 2017-08-01 | Pat Roberts | BUY | $15K–$50K | — | — | — |
| 2017-02-21 | John F Reed | BUY | $1K–$15K | — | — | — |
| 2017-01-09 | Bradley S. Schneider | BUY | $100K–$250K | — | — | — |
| 2016-10-14 | Alan S. Lowenthal | SELL | $1K–$15K | — | — | — exit |
| 2016-08-04 | K. Michael Conaway | BUY | $1K–$15K | — | — | — |
| 2016-08-03 | K. Michael Conaway | BUY | $1K–$15K | — | — | — |
| 2016-07-25 | John F Reed | BUY | $1K–$15K | — | — | — |
| 2016-07-20 | James B. Renacci | BUY | $15K–$50K | — | — | — |
| 2016-05-02 | E. Scott Rigell | SELL | $15K–$50K | — | — | — exit |
| 2016-03-17 | Alan S. Lowenthal | BUY | $1K–$15K | — | — | — |
| 2016-03-08 | E. Scott Rigell | BUY | $15K–$50K | — | — | — |
| 2016-03-07 | Alan S. Lowenthal | BUY | $1K–$15K | — | — | — |
| 2016-02-18 | James B. Renacci | SELL | $1K–$15K | — | — | — exit |
| 2016-02-18 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2016-02-12 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2016-02-11 | John F Reed | BUY | $1K–$15K | — | — | — |
| 2016-02-01 | John A. Yarmuth | BUY | $1K–$15K | — | — | — |
| 2016-01-28 | Alan S. Lowenthal | BUY | $1K–$15K | — | — | — |
| 2016-01-27 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2016-01-26 | Alan S. Lowenthal | BUY | $1K–$15K | — | — | — |
| 2016-01-21 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-12-07 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-09-30 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-09-17 | James B. Renacci | BUY | $1K–$15K | — | — | — |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
19 members of the U.S. House and Senate have disclosed Celgene Corporation transactions under the STOCK Act — 39 purchases and 31 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a CELG purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Every CELG trade is marked to the latest close in the Return column; sells matched to a prior buy show a realized round-trip return.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded CELG and how it performed.